Market Exclusive

Analyst Activity – Sanford C. Bernstein Initiates Coverage On bluebird bio (NASDAQ:BLUE) With a Market Perform

Analyst Ratings For bluebird bio (NASDAQ:BLUE)

Today, Sanford C. Bernstein initiated coverage on bluebird bio (NASDAQ:BLUE) with a Market Perform with a price target of $109.00.

There are 2 sell ratings, 5 hold ratings, 11 buy ratings on the stock.

The current consensus rating on bluebird bio (NASDAQ:BLUE) is Buy (Score: 2.50) with a consensus target price of $99.45 per share, a potential 0.05% downside.

Some recent analyst ratings include


Recent Trading Activity for bluebird bio (NASDAQ:BLUE)
Shares of bluebird bio closed the previous trading session at 98.95 down -0.55 -0.55% with 451,487 shares trading hands.

Exit mobile version